{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:48:18Z","timestamp":1772192898827,"version":"3.50.1"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1093\/humrep\/dei070","type":"journal-article","created":{"date-parts":[[2005,5,13]],"date-time":"2005-05-13T00:24:34Z","timestamp":1115943874000},"page":"2414-2420","source":"Crossref","is-referenced-by-count":62,"title":["Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome"],"prefix":"10.1093","volume":"20","author":[{"given":"Murat","family":"Y\u0131lmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan","family":"Bukan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhan","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Karako\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lhan","family":"Yetkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ksun","family":"Ayvaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuri","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,5,12]]},"reference":[{"key":"key\n\t\t\t\t20171011134416_R1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2002) Screening for diabetes. Diabetes Care25, 21\u201324.","DOI":"10.2337\/diacare.25.2007.S21"},{"key":"key\n\t\t\t\t20171011134416_R2","doi-asserted-by":"crossref","unstructured":"Atiomo WU, El Mahdi and Hardiman P (2003) Family association in women with polycystic ovary syndrome. Fertil Steril80, 143\u2013145.","DOI":"10.1016\/S0015-0282(03)00502-8"},{"key":"key\n\t\t\t\t20171011134416_R3","doi-asserted-by":"crossref","unstructured":"Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O and Blumenfeld Z (2004) Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab89, 2160\u20132165.","DOI":"10.1210\/jc.2003-031096"},{"key":"key\n\t\t\t\t20171011134416_R4","doi-asserted-by":"crossref","unstructured":"Carey AH, Chan KL, Short F, White D, Williamson R and Franks S (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf)38, 653\u2013658.","DOI":"10.1111\/j.1365-2265.1993.tb02150.x"},{"key":"key\n\t\t\t\t20171011134416_R5","doi-asserted-by":"crossref","unstructured":"Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B and Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. New Engl J Med324, 1149\u20131155.","DOI":"10.1056\/NEJM199104253241701"},{"key":"key\n\t\t\t\t20171011134416_R6","doi-asserted-by":"crossref","unstructured":"Colilla S, Cox NJ and Ehrmann DA (2001) Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab86, 2027\u20132031.","DOI":"10.1210\/jc.86.5.2027"},{"key":"key\n\t\t\t\t20171011134416_R7","doi-asserted-by":"crossref","unstructured":"Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M and Pugeat M (2003) Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab88, 3626\u20133631.","DOI":"10.1210\/jc.2003-030219"},{"key":"key\n\t\t\t\t20171011134416_R8","doi-asserted-by":"crossref","unstructured":"Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev18, 774\u2013800.","DOI":"10.1210\/er.18.6.774"},{"key":"key\n\t\t\t\t20171011134416_R9","doi-asserted-by":"crossref","unstructured":"Dunaif A, Segal K, Futterweit W and Dobrjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes38, 1165\u20131174.","DOI":"10.2337\/diab.38.9.1165"},{"key":"key\n\t\t\t\t20171011134416_R10","doi-asserted-by":"crossref","unstructured":"Dunaif A, Xia J, Book CB, Schenker E and Tang Z (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscleA potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest96, 801\u2013810.","DOI":"10.1172\/JCI118126"},{"key":"key\n\t\t\t\t20171011134416_R11","doi-asserted-by":"crossref","unstructured":"Ehrman DA, Barnes RB, Rosenfield RL, Cavaghan MK and Imperial J (1999) Prevalance of impaired glucose tolerance and diabetes in women polycystic ovary syndrome. Diabetes Care22, 141\u2013146.","DOI":"10.2337\/diacare.22.1.141"},{"key":"key\n\t\t\t\t20171011134416_R12","doi-asserted-by":"crossref","unstructured":"Ehrman DA, Kasza K, Azziz R, Legro RS and Ghazzi MN (2005) PCOS\/Troglitazone Study Group Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab90, 66\u201371.","DOI":"10.1210\/jc.2004-0229"},{"key":"key\n\t\t\t\t20171011134416_R13","doi-asserted-by":"crossref","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up Report on the Diagnosis of Diabetes Mellitus (2003). Diabetes Care26, 3160\u20133167.","DOI":"10.2337\/diacare.26.11.3160"},{"key":"key\n\t\t\t\t20171011134416_R14","doi-asserted-by":"crossref","unstructured":"Ezenwaka CE, Kalloo R, Uhlig M and Eckel J (2004) Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus. Horm Metab Res36, 238\u2013242.","DOI":"10.1055\/s-2004-814454"},{"key":"key\n\t\t\t\t20171011134416_R15","doi-asserted-by":"crossref","unstructured":"Ferriman D and Gallwey JD (1961) Clinical assesment of body hair growth in women. J Clin Endocrinol Metab21, 1440\u20131447.","DOI":"10.1210\/jcem-21-11-1440"},{"key":"key\n\t\t\t\t20171011134416_R16","doi-asserted-by":"crossref","unstructured":"Ferriman D and Purdie AW (1979) The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol (Oxf)11, 291\u2013300.","DOI":"10.1111\/j.1365-2265.1979.tb03077.x"},{"key":"key\n\t\t\t\t20171011134416_R17","doi-asserted-by":"crossref","unstructured":"Franks S (1995) Polycystic over syndrome. New Engl J Med333, 853\u2013861.","DOI":"10.1056\/NEJM199509283331307"},{"key":"key\n\t\t\t\t20171011134416_R18","doi-asserted-by":"crossref","unstructured":"Govind A, Obhrai MS and Clayton RN (1999) Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab84, 38\u201343.","DOI":"10.1210\/jcem.84.1.5382"},{"key":"key\n\t\t\t\t20171011134416_R19","doi-asserted-by":"crossref","unstructured":"Hague WM, Adams J, Reeders ST, Peto TE and Jacobs HS (1988) Familial polycystic ovaries: a genetic disease? Clin Endocrinol (Oxf)29, 593\u2013605.","DOI":"10.1111\/j.1365-2265.1988.tb03707.x"},{"key":"key\n\t\t\t\t20171011134416_R20","doi-asserted-by":"crossref","unstructured":"Homburg R (2003) What is polycystic ovarian syndrome? Hum Reprod17, 2495\u20132499.","DOI":"10.1093\/humrep\/17.10.2495"},{"key":"key\n\t\t\t\t20171011134416_R21","doi-asserted-by":"crossref","unstructured":"Hotta K, Funalshashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N et al. (2000) Plasma concentrations of a novel adipose spesific protein adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol20, 1595\u20131599.","DOI":"10.1161\/01.ATV.20.6.1595"},{"key":"key\n\t\t\t\t20171011134416_R22","doi-asserted-by":"crossref","unstructured":"Jahanfar S, Eden JA, Warren P, Seppala M and Nguyen TV (1995) A twin study of polycystic ovary syndrome. Fertil Steril63, 478\u2013486.","DOI":"10.1016\/S0015-0282(16)57412-3"},{"key":"key\n\t\t\t\t20171011134416_R23","doi-asserted-by":"crossref","unstructured":"Kahsar-Miller MD, Nixon C, Boots LR, Go RC and Azziz R (2001) Prevalence of polycystic ovary syndrome in first-degree relatives of patients with PCOS. Fertil Steril75, 53\u201358.","DOI":"10.1016\/S0015-0282(00)01662-9"},{"key":"key\n\t\t\t\t20171011134416_R24","doi-asserted-by":"crossref","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G and MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab85, 2402\u20132410.","DOI":"10.1210\/jcem.85.7.6661"},{"key":"key\n\t\t\t\t20171011134416_R25","doi-asserted-by":"crossref","unstructured":"Kaushal R, Parchure N, Bano G, Kaski JC and Nussey SS (2004) Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries. Clin Endocrinol (Oxf)60, 322\u2013328.","DOI":"10.1111\/j.1365-2265.2004.01981.x"},{"key":"key\n\t\t\t\t20171011134416_R26","doi-asserted-by":"crossref","unstructured":"Kelestimur F, Cetin M, Pasaoglu H, Coksevim B, Cetinkaya F, Unluhizarci K, Unal S and Koker AH (1999) The prevalence and identification of risk factors for type 2 diabetes mellitus and impaired glucose tolerance in Kayseri, central Anatolia, Turkey. Acta Diabetol36, 85\u201391.","DOI":"10.1007\/s005920050150"},{"key":"key\n\t\t\t\t20171011134416_R27","doi-asserted-by":"crossref","unstructured":"Kershaw EE and Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab89, 2548\u20132556.","DOI":"10.1210\/jc.2004-0395"},{"key":"key\n\t\t\t\t20171011134416_R28","doi-asserted-by":"crossref","unstructured":"Kim K, Lee K, Soo Y, Moon YS and Sul HS (2001) A cysteine-rich adipocyte tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem276, 1152\u20131156.","DOI":"10.1074\/jbc.C100028200"},{"key":"key\n\t\t\t\t20171011134416_R29","doi-asserted-by":"crossref","unstructured":"Legro RS (2003) Polycystic ovary syndrome and cardiovascular disease:a premature association. Endocr Rev24, 302\u2013312.","DOI":"10.1210\/er.2003-0004"},{"key":"key\n\t\t\t\t20171011134416_R30","doi-asserted-by":"crossref","unstructured":"Legro RS, Driscoll D, Strauss FoxJ III JF and Dunaif A (1998) Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA95, 14956\u201314960.","DOI":"10.1073\/pnas.95.25.14956"},{"key":"key\n\t\t\t\t20171011134416_R31","doi-asserted-by":"crossref","unstructured":"Legro RS, Kunselman AR, Dodson WC and Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab84, 165\u2013169.","DOI":"10.1097\/00006254-199906000-00019"},{"key":"key\n\t\t\t\t20171011134416_R32","doi-asserted-by":"crossref","unstructured":"Legro RS, Bentley-Lewis R, Driscoll D, Wang SC and Dunaif A (2002) Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab87, 2128\u20132133.","DOI":"10.1210\/jcem.87.5.8513"},{"key":"key\n\t\t\t\t20171011134416_R33","doi-asserted-by":"crossref","unstructured":"Loverro G, Lorusso F, Mei L, Depalo R, Cormio G and Selvaggi L (2002) The plasma homocysteine levels are increased in polycystic ovary syndrome. Gynecol Obstet Invest53, 157\u2013162.","DOI":"10.1159\/000058367"},{"key":"key\n\t\t\t\t20171011134416_R34","doi-asserted-by":"crossref","unstructured":"Lunde O, Magnus P, Sandvik L and Hoglo S (1989) Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest28, 23\u201330.","DOI":"10.1159\/000293493"},{"key":"key\n\t\t\t\t20171011134416_R35","doi-asserted-by":"crossref","unstructured":"Matsuda M and De Fronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care22, 1462\u20131470.","DOI":"10.2337\/diacare.22.9.1462"},{"key":"key\n\t\t\t\t20171011134416_R36","doi-asserted-by":"crossref","unstructured":"Matsuzawa Y, Funahashi T, Kihara S and Shimomura I (2004) Adiponectine and metabolic syndrome. Arterioscler Thromb Vasc Biol24, 29\u201333.","DOI":"10.1161\/01.ATV.0000099786.99623.EF"},{"key":"key\n\t\t\t\t20171011134416_R37","doi-asserted-by":"crossref","unstructured":"Matthews DR and Hosker JP (1985) and Rudenski ASl Homeostasis model assesssment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia28, 412\u2013419.","DOI":"10.1007\/BF00280883"},{"key":"key\n\t\t\t\t20171011134416_R38","doi-asserted-by":"crossref","unstructured":"Norman RJ, Masters S and Hague W (1996) Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertil Steril66, 942\u2013947.","DOI":"10.1016\/S0015-0282(16)58687-7"},{"key":"key\n\t\t\t\t20171011134416_R39","doi-asserted-by":"crossref","unstructured":"Nyholm B, Nielsen MF, Kristensen K, Nielsen S, Ostergard T, Pedersen SB, Christiansen T, Richelsen B, Jensen MD and Schmitz O (2004) Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients. Eur J Endocrinol150, 207\u2013214.","DOI":"10.1530\/eje.0.1500207"},{"key":"key\n\t\t\t\t20171011134416_R40","doi-asserted-by":"crossref","unstructured":"Orio F, Palomba S, Di Biase S, Calao A, Tauchmanova L, Savastano S, Labella D, Russo T, Zullo F and Lombardi G (2003a) Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome. J Clin. Endocrinol Metabol88, 673\u2013679.","DOI":"10.1210\/jc.2002-021142"},{"key":"key\n\t\t\t\t20171011134416_R41","doi-asserted-by":"crossref","unstructured":"Orio F Jr, Palomba S, Cascella T, Milan G, Mioni R, Pagano C, Zullo F, Colao A, Lombardi G and Vettor R (2003b) Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab88, 2619\u20132623.","DOI":"10.1210\/jc.2002-022033"},{"key":"key\n\t\t\t\t20171011134416_R42","doi-asserted-by":"crossref","unstructured":"Orio F Jr, Palomba S, Cascella T, Di Biase SLabella D, Russo T, Savastano S, Zullo F, Colao A, Vettor R and Lombardi G (2004) Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. J Clin Endocrinol Metab89, 5110\u20135115.","DOI":"10.1210\/jc.2004-0109"},{"key":"key\n\t\t\t\t20171011134416_R43","doi-asserted-by":"crossref","unstructured":"Ouchi N, Kihara S, Funahashi T, Funahashi T and Walsh K (2003) Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol14, 561\u2013566.","DOI":"10.1097\/00041433-200312000-00003"},{"key":"key\n\t\t\t\t20171011134416_R44","doi-asserted-by":"crossref","unstructured":"Panidis D, Kourtis A, Farmakiotis D, Mouslech T, Rousso D and Koliakos G (2003) Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod18, 1790\u20131796.","DOI":"10.1093\/humrep\/deg353"},{"key":"key\n\t\t\t\t20171011134416_R45","doi-asserted-by":"crossref","unstructured":"Pankow JS, Jacobs DR Jr, Steinberger J, Moran A and Sinaiko AR (2004) Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care27, 775\u2013780.","DOI":"10.2337\/diacare.27.3.775"},{"key":"key\n\t\t\t\t20171011134416_R46","doi-asserted-by":"crossref","unstructured":"Pontiroli AE, Monti LD, Pizzini A and Piatti P (2000) Familial clustering of arterial blood pressure, HDL cholesterol, and pro-insulin but not of insulin resistance and microalbuminuria in siblings of patients with type 2 diabetes. Diabetes Care23, 1359\u20131364.","DOI":"10.2337\/diacare.23.9.1359"},{"key":"key\n\t\t\t\t20171011134416_R47","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod19, 41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"key\n\t\t\t\t20171011134416_R48","doi-asserted-by":"crossref","unstructured":"Schachter M, Raziel A, Friedler S, Strassburger D, Bern O and Ron-El R (2003) Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod18, 721\u2013727.","DOI":"10.1093\/humrep\/deg190"},{"key":"key\n\t\t\t\t20171011134416_R49","doi-asserted-by":"crossref","unstructured":"Sir-Petermann T, Angel B, Maliqueo M, Carvajal F, Santos JL and Perez-Bravo F (2002) Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia45, 959\u2013964.","DOI":"10.1007\/s00125-002-0836-3"},{"key":"key\n\t\t\t\t20171011134416_R50","doi-asserted-by":"crossref","unstructured":"Spranger J, Mohlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlosser HW, Brabant G and Schofl C (2004) Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf)61, 738\u2013746.","DOI":"10.1111\/j.1365-2265.2004.02159.x"},{"key":"key\n\t\t\t\t20171011134416_R51","doi-asserted-by":"crossref","unstructured":"Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD and Mickle DA (2003) Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial cell interaction. Circulation108, 736\u2013740.","DOI":"10.1161\/01.CIR.0000084503.91330.49"},{"key":"key\n\t\t\t\t20171011134416_R52","doi-asserted-by":"crossref","unstructured":"Wijeyaratne CN, Nirantharakumar K, Balen AH, Barth JH, Sheriff R and Belchetz PE (2004) Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity? Clin Endocrinol (Oxf)60, 560\u2013567.","DOI":"10.1111\/j.1365-2265.2004.02019.x"},{"key":"key\n\t\t\t\t20171011134416_R53","doi-asserted-by":"crossref","unstructured":"Wild RA, Painter RD, Coulson PB, Carruth KB and Ranney RB (1985) Lipoprotein lipid concentrations as cardiovascular risk in patients with polycystic ovary syndrome. J Clin Endocrinol Metab61, 946\u2013950.","DOI":"10.1210\/jcem-61-5-946"},{"key":"key\n\t\t\t\t20171011134416_R54","doi-asserted-by":"crossref","unstructured":"Wild S, Pierpoint T, McKeigue P and Jacobs H (2000) Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf)52, 595\u2013600.","DOI":"10.1046\/j.1365-2265.2000.01000.x"},{"key":"key\n\t\t\t\t20171011134416_R55","doi-asserted-by":"crossref","unstructured":"Y\u0131ld\u0131z BO, Yaral\u0131 H, Oguz H and Bayraktar M (2003) Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. Clin Endocrinol Metab88, 2031\u20132036.","DOI":"10.1210\/jc.2002-021499"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/20\/9\/2414\/6953687\/dei070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T09:34:56Z","timestamp":1586252096000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/20\/9\/2414\/2356729\/Glucose-intolerance-insulin-resistance-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,12]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2005,5,12]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dei070","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,5,12]]}}}